Physiol Rev Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Rev. 79: 167-173, 1999;
0031-9333/99 $15.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KOPITO, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KOPITO, R. R.

PHYSIOLOGICAL REVIEWS   Vol. 79 No. 1 January 1999, pp. S167-S173
Copyright ©1999 The American Physiological Society

Biosynthesis and Degradation of CFTR

RON R. KOPITO

Department of Biological Sciences, Stanford University, Stanford, California

Kopito, Ron R. Biosynthesis and Degradation of CFTR. Physiol. Rev. 79, Suppl.: S167-S173, 1999. --- Many of the mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that cause cystic fibrosis interfere with the folding and biosynthetic processing of nascent CFTR molecules in the endoplasmic reticulum. Mutations in the cytoplasmic nucleotide binding domains, including the common allele Delta F508, decrease the efficiency of CFTR folding, reduce the probability of its dissociation from molecular chaperones, and largely prevent its maturation through the secretory pathway to the plasma membrane. These mutant CFTR molecules are rapidly degraded by cytoplasmic proteasomes by a process that requires covalent modification by multiubiquitination. The effects of temperature and chemical chaperones on the intracellular processing of mutant CFTR molecules suggest that strategies aimed at increasing the folding yield of this protein in vivo may eventually lead to the development of novel therapies for cystic fibrosis.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. L. Berger, C. O. Randak, L. S. Ostedgaard, P. H. Karp, D. W. Vermeer, and M. J. Welsh
Curcumin Stimulates Cystic Fibrosis Transmembrane Conductance Regulator Cl- Channel Activity
J. Biol. Chem., February 18, 2005; 280(7): 5221 - 5226.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Bhat, M. Zabalawi, M. C. Willingham, G. S. Shelness, M. J. Thomas, and M. G. Sorci-Thomas
Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions
J. Lipid Res., July 1, 2004; 45(7): 1207 - 1220.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. N. Henderson, J. Zhang, B. W. Evans, and K. Redding
Disassembly and Degradation of Photosystem I in an in Vitro System Are Multievent, Metal-dependent Processes
J. Biol. Chem., October 10, 2003; 278(41): 39978 - 39986.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Akhavan, R. Atanasiu, and A. Shrier
Identification of a COOH-terminal Segment Involved in Maturation and Stability of Human Ether-a-go-go-related Gene Potassium Channels
J. Biol. Chem., October 10, 2003; 278(41): 40105 - 40112.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Hofmann, C. Philbrook, K.-D. Gerbitz, and M. F. Bauer
Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product
Hum. Mol. Genet., August 15, 2003; 12(16): 2003 - 2012.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. C. de Jong, W. A. van der Vliet, L. P. W. J. van den Heuvel, P. H. G. M. Willems, N. V. A. M. Knoers, and R. J. M. Bindels
Functional Expression of Mutations in the Human NaCl Cotransporter: Evidence for Impaired Routing Mechanisms in Gitelman's Syndrome
J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1442 - 1448.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. Yoo, B. D. Moyer, S. Bannykh, H.-M. Yoo, J. R. Riordan, and W. E. Balch
Non-conventional Trafficking of the Cystic Fibrosis Transmembrane Conductance Regulator through the Early Secretory Pathway
J. Biol. Chem., March 22, 2002; 277(13): 11401 - 11409.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. N. Manganas, Q. Wang, R. H. Scannevin, D. E. Antonucci, K. J. Rhodes, and J. S. Trimmer
Identification of a trafficking determinant localized to the Kv1 potassium channel pore
PNAS, October 31, 2001; (2001) 241403898.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Riedel, O. Levy, and N. Carrasco
Post-transcriptional Regulation of the Sodium/Iodide Symporter by Thyrotropin
J. Biol. Chem., June 8, 2001; 276(24): 21458 - 21463.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. N. Manganas, Q. Wang, R. H. Scannevin, D. E. Antonucci, K. J. Rhodes, and J. S. Trimmer
Identification of a trafficking determinant localized to the Kv1 potassium channel pore
PNAS, November 20, 2001; 98(24): 14055 - 14059.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online